Download our NEW Mobile App!
Diabetes Resource Centre Logo

Patient Resources

Get Healthy!

  • Posted October 29, 2024

Semaglutide Helps Prevent Kidney Damage in People with Obesity

A new study finds semaglutide, the active ingredient in Ozempic and Wegovy, reduced kidney damage by up to 52% in people with obesity.

Health News is provided as a service to Diabetes Resource Centre site users by HealthDay. Diabetes Resource Centre nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.

Share

Tags

2024 © All Rights Reserved. Privacy Policy